survival outcomes with balixafortide plus eribulin for patients with her2-metastatic breast cancer
Published 2 years ago • 18 plays • Length 2:09Download video MP4
Download video MP3
Similar videos
-
3:08
dr. timothy pluard on balixafortide plus eribulin for metastatic breast cancer
-
2:14
survival in premenopausal hr /her2- breast cancer with micro-metastasis and 21-gene score
-
7:30
neratinib plus fulvestrant for her2 mutant, non-amplified metastatic breast cancer
-
3:05
overall survival with palbociclib plus fulvestrant
-
1:51
tucatinib combination improved survival in her2–positive breast cancer
-
3:40
treatment with eribulin in metastatic breast cancer
-
4:11
ribociclib plus endocrine therapy improves survival in premenopausal patients with metastatic br...
-
2:42
eribulin as treatment for metastatic breast cancer
-
6:51
treatment with eribulin mesylate in metastatic breast cancer
-
5:10
paloma-3: overall survival (os) with palbociclib plus fulvestrant in hr ,her2_ abc
-
1:13
overall survival data of the monarch-2 trial in hr /her2- breast cancer
-
1:39
treatment for her2 metastatic breast cancer
-
2:49
neratinib, trastuzumab fulvestrant for her2-mutant, hr , metastatic breast cancer
-
4:12
eribulin in recurrent metastatic er breast cancer
-
19:38
medical update: her2-positive metastatic breast cancer
-
1:16
her2climb-04: tucatinib plus t-dxd for her2 breast cancer
-
3:09
overall survival results from monaleesa-3 study on ribociclib plus fulvestrant in advanced breas...
-
4:38
monarch 2: overall survival results from abermaciclib plus fulvestrant in hr her2- advanced bre...
-
8:39
final overall survival analysis of monarch 1